KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jun 17, 2026 - 3:59PM >>  ABB India 7019  [ 1.35% ]  ACC 1348.45  [ -0.68% ]  Ambuja Cements 426.2  [ -0.54% ]  Asian Paints 2747.5  [ 0.30% ]  Axis Bank 1365.6  [ -0.19% ]  Bajaj Auto 9934.1  [ -0.09% ]  Bank of Baroda 275.3  [ -0.22% ]  Bharti Airtel 1858.05  [ 0.93% ]  Bharat Heavy 384.15  [ 0.33% ]  Bharat Petroleum 311.8  [ 0.45% ]  Britannia Industries 5222.25  [ 0.49% ]  Cipla 1372.75  [ -0.63% ]  Coal India 451  [ 1.38% ]  Colgate Palm 2097.1  [ 1.88% ]  Dabur India 435.7  [ 1.54% ]  DLF 629.7  [ 2.72% ]  Dr. Reddy's Lab. 1277.85  [ -0.11% ]  GAIL (India) 175.75  [ 0.14% ]  Grasim Industries 3137.85  [ -0.73% ]  HCL Technologies 1159.35  [ 3.59% ]  HDFC Bank 784.7  [ 0.96% ]  Hero MotoCorp 5028.2  [ 0.11% ]  Hindustan Unilever 2201.15  [ 2.10% ]  Hindalco Industries 982.4  [ -3.04% ]  ICICI Bank 1334.9  [ 0.54% ]  Indian Hotels Co. 694.3  [ 0.64% ]  IndusInd Bank 925.75  [ -0.79% ]  Infosys 1143.3  [ 0.71% ]  ITC 291.75  [ 1.32% ]  Jindal Steel 1139.1  [ -0.92% ]  Kotak Mahindra Bank 408.1  [ 0.60% ]  L&T 4185.7  [ 0.34% ]  Lupin 2270.1  [ -0.15% ]  Mahi. & Mahi 3137.8  [ 0.09% ]  Maruti Suzuki India 13692.85  [ -0.81% ]  MTNL 31.27  [ 0.48% ]  Nestle India 1391.9  [ 1.27% ]  NIIT 106.32  [ 19.13% ]  NMDC 88.07  [ -0.42% ]  NTPC 355.45  [ 2.10% ]  ONGC 248.25  [ 1.87% ]  Punj. NationlBak 107.95  [ 0.05% ]  Power Grid Corpn. 285.65  [ 0.02% ]  Reliance Industries 1327.85  [ 1.59% ]  SBI 1015.5  [ -0.49% ]  Vedanta 300  [ -0.86% ]  Shipping Corpn. 308.45  [ -0.79% ]  Sun Pharmaceutical 1800.65  [ -0.32% ]  Tata Chemicals 729.6  [ -0.77% ]  Tata Consumer 1129.45  [ 2.64% ]  Tata Motors Passenge 393.6  [ -0.82% ]  Tata Steel 196  [ -0.71% ]  Tata Power Co. 402.1  [ -0.45% ]  Tata Consult. Serv. 2198.85  [ 1.72% ]  Tech Mahindra 1446.1  [ 1.45% ]  UltraTech Cement 11380  [ -0.82% ]  United Spirits 1300  [ 2.27% ]  Wipro 182.7  [ 0.72% ]  Zee Entertainment 111.29  [ 2.48% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

17 June 2026 | 03:56

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 203.14 Face Value 10.00
Bookclosure 19/09/2025 52Week High 448 EPS 7.11 P/E 31.56
Market Cap. 304.25 Cr. 52Week Low 217 P/BV / Div Yield (%) 1.10 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.